Antibiotice S.A. (BVB:ATB)
1.834
+0.036 (2.00%)
At close: Apr 8, 2026
Antibiotice Balance Sheet
Financials in millions RON. Fiscal year is January - December.
Millions RON. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 9.94 | 2.68 | 1.81 | 1.73 | 2.11 |
Cash & Short-Term Investments | 9.94 | 2.68 | 1.81 | 1.73 | 2.11 |
Cash Growth | 270.87% | 48.31% | 4.66% | -18.18% | -66.64% |
Accounts Receivable | 294.6 | 275.39 | 221.13 | 196.51 | 269.76 |
Other Receivables | 12.55 | 9.15 | 12.78 | 6.22 | 3.99 |
Receivables | 307.15 | 284.54 | 233.91 | 202.73 | 273.75 |
Inventory | 184.61 | 170.46 | 161.67 | 143.07 | 106.02 |
Prepaid Expenses | - | - | 3.49 | - | - |
Other Current Assets | 3.98 | 17.01 | 0.41 | 4.13 | 3.13 |
Total Current Assets | 505.69 | 474.69 | 401.28 | 351.66 | 385.01 |
Property, Plant & Equipment | 760.72 | 749.4 | 692.36 | 599.9 | 480.54 |
Other Intangible Assets | 28.89 | 21.27 | 12.53 | 2.46 | 29.84 |
Long-Term Deferred Charges | 41.06 | 33.9 | 33 | 30.29 | - |
Other Long-Term Assets | 56.2 | - | - | - | - |
Total Assets | 1,393 | 1,279 | 1,139 | 984.32 | 895.39 |
Accounts Payable | 133.36 | 83.5 | 73.66 | 65.4 | 66.32 |
Accrued Expenses | 14.99 | 34.27 | 9.69 | 2.87 | 8.4 |
Short-Term Debt | 101.32 | 57.58 | 32.44 | 34.01 | 87.16 |
Current Income Taxes Payable | - | - | - | - | 9.61 |
Current Unearned Revenue | 0.52 | 3.83 | 0.73 | 0.6 | 3.47 |
Other Current Liabilities | 0.18 | 55.88 | 73.95 | 33.81 | 24.17 |
Total Current Liabilities | 250.36 | 235.06 | 190.47 | 136.69 | 199.14 |
Long-Term Debt | 135.74 | 85.72 | 36.75 | 46.97 | 57.62 |
Long-Term Unearned Revenue | 10.01 | 5.15 | 1.59 | 1.86 | 2.16 |
Long-Term Deferred Tax Liabilities | 64.38 | 59.03 | 63.4 | 57.82 | 31.48 |
Other Long-Term Liabilities | -0 | - | - | - | - |
Total Liabilities | 460.49 | 384.95 | 292.21 | 243.34 | 290.4 |
Common Stock | 67.13 | 67.13 | 67.13 | 67.13 | 67.13 |
Retained Earnings | 662.75 | 613.23 | 554.41 | 476.09 | -33.15 |
Comprehensive Income & Other | 202.19 | 213.95 | 225.42 | 197.76 | 571.01 |
Shareholders' Equity | 932.07 | 894.31 | 846.96 | 740.98 | 604.99 |
Total Liabilities & Equity | 1,393 | 1,279 | 1,139 | 984.32 | 895.39 |
Total Debt | 237.05 | 143.29 | 69.19 | 80.98 | 144.78 |
Net Cash (Debt) | -227.11 | -140.61 | -67.38 | -79.25 | -142.67 |
Net Cash Per Share | -0.34 | -0.21 | -0.10 | -0.12 | -0.21 |
Filing Date Shares Outstanding | 671.34 | 671.34 | 671.34 | 671.34 | 671.34 |
Total Common Shares Outstanding | 671.34 | 671.34 | 671.34 | 671.34 | 671.34 |
Working Capital | 255.33 | 239.64 | 210.81 | 214.97 | 185.87 |
Book Value Per Share | 1.39 | 1.33 | 1.26 | 1.10 | 0.90 |
Tangible Book Value | 903.19 | 873.04 | 834.44 | 738.52 | 575.15 |
Tangible Book Value Per Share | 1.35 | 1.30 | 1.24 | 1.10 | 0.86 |
Land | 204.79 | 204.79 | 204.79 | 203.67 | 189.93 |
Buildings | 385.41 | 377.61 | 312.77 | 267.97 | 157.46 |
Machinery | 372.91 | 344.5 | 296.48 | 271.21 | 234.38 |
Construction In Progress | 34.82 | 20.57 | 42.67 | 9.09 | 64.71 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.